Cure My Disease

Don't miss your cure!

 Log in / Sign up

New contact lens aims to beat digital eye fatigue

NCT ID NCT07488208

Symptom relief Sponsor: Southern College of Optometry Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested two types of stenfilcon A contact lenses to see if one reduces eye strain from digital screens better than the other. Thirty adults who already wear contacts and have computer vision syndrome wore each lens design for five days. The lenses were compared using questionnaires and vision tests. The goal is to find a lens that makes screen time more comfortable.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Stenfilcon A contact lens with Digital Boost technology (0.3D add power)
What this could lead to
If successful, this lens design could offer a simple way to reduce eye strain and discomfort for people who spend long hours on digital devices.
What could go wrong
This is a small, early-stage crossover study with only 30 participants. The benefits may be subtle and not apply to everyone. It does not test long-term effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

30 people

The number who actually took part.

Started

May 2025

Finished

Sep 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 35 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Score of \>6 on CVS-Q * Male or female * Age \>18 years to 35 years of age * Experienced, well-adapted contact lens wearers * Spherical equivalent refractive error between ±6.00DS with astigmatism \< -0.75D * Normal stereopsis and binocular status Exclusion Criteria: * Monovision * History of refractive surgery * Binocular vision abnormalities * Current ocular or systemic disease that may affect the eye * Allergic reactions of ocular surfaces or adnexa that may be induced or exaggerated by wearing contact lenses or use of contact lens solutions.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Accommodation are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

eye accommodation disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Accommodation Computer vision syndrome

Contacts and locations

Locations

  • Southern College of Optometry

    Memphis, Tennessee, 38104, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.